Medical device recalls Moderate risk

Cytocell Ltd. recalls Aquarius LPH 511-A CRLF2 Distal Probe Green, model no. LPH 511-A The CRLF2 Distal probe, labelled in green, consists of…

Recall date
December 22, 2020
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-1099-2021
FDA classification
Class II
Brand / firm
Cytocell Ltd.
Sold / distributed
Domestic distribution to California, Illinois, Michigan, Minnesota, New Jersey, Texas, and Washington. Foreign distribution to Canada.

Why it was recalled

Users may observe very faint additional locus specific signals at 11q13. There is a low risk of a normal sample being reported as not normal in a resulting laboratory developed test (LDT) that utilizes the LPH511-A CRLF2 Distal Probe Green.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Aquarius LPH 511-A CRLF2 Distal Probe Green, model no. LPH 511-A The CRLF2 Distal probe, labelled in green, consists of two probes (71kb and 131kb) that are situated distal (telomeric) to the CRLF2 gene

Get recall alerts

Free email alert whenever Cytocell Ltd. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Cytocell Ltd.